LDL receptor
Showing 1 - 25 of 8,652
Familial Hypercholesterolemia, Familial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein B, Familial
Recruiting
- Familial Hypercholesterolemia
- +7 more
- Research-based genetic test for Familial Hypercholesterolemia
-
Vancouver, British Columbia, Canada
- +1 more
Jan 31, 2022
Endometriosis Trial in University Park (Salsalate Pill, Placebo)
Recruiting
- Endometriosis
- Salsalate Pill
- Placebo
-
University Park, PennsylvaniaThe Pennsylvania State University
Dec 13, 2022
Familial Hypercholesterolemia Trial
Not yet recruiting
- Familial Hypercholesterolemia
- (no location specified)
Apr 11, 2023
Patients With High Cholesterol and Normal Volunteers
Completed
- Homozygous Familial Hypercholesterolemic
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 12, 2023
Oxidized LDL With Oxygen Therapy in Acute Coronary Syndrome.
Unknown status
- Acute Coronary Syndrome
- Oxidized-LDL gene polymorphism
- (no location specified)
Feb 4, 2019
COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction, COVID-19-Associated Thromboembolism Trial in Chongqing
Active, not recruiting
- COVID-19 Stress Syndrome
- +5 more
- Atorvastatin Calcium Tablets
-
Chongqing, Chongqing, ChinaResidential Address
May 1, 2023
Familial Hypobetalipoproteinemia, Familial Hypobetalipoproteinemia - Heterozygous Form Trial (Administration of deuterated
Not yet recruiting
- Familial Hypobetalipoproteinemia
- Familial Hypobetalipoproteinemia - Heterozygous Form
- Administration of deuterated compounds for kinetic study
- (no location specified)
Oct 5, 2022
Lipids, Lipid Metabolism, Healthy Trial in Reading, Guildford (High SFA diet (Diet 1), Low SFA diet (Diet 2))
Completed
- Lipids
- +2 more
- High SFA diet (Diet 1)
- Low SFA diet (Diet 2)
-
Reading, Berkshire, United Kingdom
- +1 more
Oct 15, 2021
Glucagon-like Peptide-1 Receptor Agonists According to Type 2
Recruiting
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Bari, ItalyAzienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023
The Rogosin Institute Homozygous Familial Hypercholesterolemia
Recruiting
- Homozygous Familial Hypercholesterolemia
-
New York, New YorkThe Rogosin Institute, Weill Cornell Medical College
Feb 28, 2022
Dietary Habits, Nutritional Knowledge and Physical Activity
Recruiting
- Breast Cancer
-
Aviano, Pordonone, ItalyIRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
Oct 5, 2023
Acute Coronary Syndrome Trial in Baltimore (Evolocumab, Placebo)
Active, not recruiting
- Acute Coronary Syndrome
- Evolocumab
- Placebo
-
Baltimore, MarylandSteven Paul Schulman
Jan 19, 2022
Endometriosis Trial in New Haven (simvastatin 10mg, Bazedoxifene 20/Estrogens,Con 0.45Mg Tb, Placebo)
Recruiting
- Endometriosis
- simvastatin 10mg
- +2 more
-
New Haven, ConnecticutThe John B. Pierce Laboratory
Dec 8, 2022
Type 2 Diabetes, Inflammation, Insulin Sensitivity/Resistance Trial in Montréal (Omega-3 fatty acids)
Recruiting
- Type 2 Diabetes
- +3 more
- Omega-3 fatty acids
-
Montréal, Quebec, CanadaMontreal Clinical Research Institute
Aug 27, 2021
Endometriosis Trial in University Park (Atorvastatin)
Recruiting
- Endometriosis
-
University Park, PennsylvaniaThe Pennsylvania State University
Apr 8, 2022
Apelin/ Apelin Receptor Genes and Coronary Artery Disease in
Completed
- Coronary Artery Disease
- Hypertension
-
Damascus, Syrian Arab RepublicDamascus University- Faculty of Pharmacy- Research and Graduate
Oct 27, 2022
Familial Hypercholesterolemia, Nutrition, Healthy, Cholesterol, Elevated Trial in Québec (Canada's Food Guide principles (CFG
Recruiting
- Familial Hypercholesterolemia
- +4 more
- Canada's Food Guide principles (CFG diet)
- Standard North American diet (NAD diet)
-
Québec, CanadaInstitute on nutrition and functional foods, Laval University
Jan 10, 2022
Pre-diabetes Trial in Québec (Low fat diet, High fat diet)
Recruiting
- Pre-diabetes
- Low fat diet
- High fat diet
-
Québec, Quebec, CanadaInstitute of Nutrition and Functional Foods (INAF)
Jul 20, 2023
Peritoneal Dialysis Trial (Melatonin, )
Not yet recruiting
- Peritoneal Dialysis
- Melatonin
- placebo
- (no location specified)
Oct 21, 2023
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Cholesterol metabolism disruption
-
Quebec city, Quebec, CanadaCHU de Québec-Université Laval
Oct 17, 2022
Hypobetalipoproteinemia Trial in Nantes (hypobetalipoproteinemia genetic and genotypic screening)
Completed
- Hypobetalipoproteinemia
- hypobetalipoproteinemia genetic and genotypic screening
-
Nantes, FranceCHU de Nantes
Feb 22, 2022
Atherosclerotic Cardiovascular Disease Trial in Jacksonville (Evolocumab, Placebo)
Completed
- Atherosclerotic Cardiovascular Disease
- Evolocumab
- Placebo
-
Jacksonville, FloridaUniversity of Florida
Feb 16, 2022
Type 2 Diabetes Trial in Doral (RGT001-075, Placebo)
Active, not recruiting
- Type 2 Diabetes Mellitus
- RGT001-075
- Placebo
-
Doral, FloridaAxon Clinical Research
May 17, 2022
Gout, Chronic Kidney Disease, Renal Transplantation Trial in Paris (Anakinra 100Mg/0.67Ml Inj Syringe, Prednisone, Placebo of
Recruiting
- Gout
- +2 more
- Anakinra 100Mg/0.67Ml Inj Syringe
- +3 more
-
Paris, Ile-De-France, FranceRhumathology department
Aug 22, 2022
In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)
Not yet recruiting
- In-stent Restenosis
- Colchicine
- +4 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023